(CERS) Bull Dunebug + Bull AB=CD Harmonic ComboI am long this stock since Dec. '23.
For the last 12 years CERS has behaved in a cyclical manner. I plotted multi-pivot and maximum excursion lines in solid and dashed yellow. These lines conservatively characterize the range's boundaries and reveal that it's expanding. The black 2.5 year down trend line has been violated and retested. I plotted a down sloping Schiff median line set and it's warning lines along with an up sloping Pendulum median line set.
Price has printed two large harmonic patterns; Bull Dunebug(distinct due to the use of 0.707 B point and 1.13 D point) whose CD leg is a Bull AB=CD. Pattern targets are plotted in dark green(high to low .236, .382 & .786 levels are dotted).
After giving a signal in mid '23, RSI and price printed a positive divergence. Note the action around the Schiff warning line and the retest of the lower maximum excursion line. Note the down trend line breakout and retest. Note the retest of the retest and how price is currently interacting with the up sloping Pendulum lower median line. The current weekly bar is showing great 'separation' from the lows of the median line test.
I believe that price is in a harmonic range. To me that means that the bullish patterns ought to work and that I should expect a bigger move than the standard harmonic model would suggest.
Buy a retest of the up sloping lower median line or buy at the market and trend follow with a 16 bar Donchian line. As it stands, I'm waiting for a momentum push(likely well above the .236 NHR level) and pullback to establish a new median line set. That notwithstanding, always be mindful of price action at the .236 retrace.
This one is for the patient believer. I hope this is, in any way, useful to someone. Best of luck to the longs!
CERS trade ideas
CERUS Long idea on watchPositive news on phase 3 trials.
Possible US food & drug admin application next year 2025
8.5 times the usual 20 daily volume average.
Red to green reversal.
This all points towards likely higher prices. If their application next year gets approved expect a monster move. Investors will likely try to front run this.
Cerus Corporation Buy TF D1 TP = 2.98On the daily chart, the trend started on May 19 (linear regression channel).
There is a high probability of profit. Possible take profit level is 2.98
But do not forget about the SL = 1.74
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am very interested in it. Thank you!
Good Luck!
Regards, WeBelieveInTrading
Dual timeframe alignment - MoxiesAn additional example of "aligning" timeframes with Moxie.
Here we pass on an initial trampoline setup as hourly is
not quite ready. By waiting, the entry area is much
closer to the subsequent desired move in price.
As noted on chart, simply one approach.
Hopefully this provides some insight(s).
CersCerus company
Industry: Health
Industry: Biotechnology and pharmaceuticals
By the end of 2000 the stock had peaked at $ 81.88
From the beginning of 2021 the stock has been on sale until 2004
A down trend has ended since we are in the trading range (accumulation?) Of about 17 years
I have been following the stock for a year
After identifying the up trust in December 2020 and realizing that the price has gone down for a level check in the monthly term
And most often produced Spring (shaken out)
Enter the Spring in a monthly chart and weekly schedule of a double-bottom.
daily chart, opened long position 28/7/21
A very small risk allowed me to buy a large amount of shares.
Currently risk-free in the positon, I have increased quantities along the way.
$CERSEntry price : 6.99
Fundamentals :
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 38%
- EPS % Chg (Previous Qtr): 31%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 31%
- Sales % Chg (Previous Qtr): 18%
- 3-Year Sales Growth Rate: 27%
- Annual Pre -Tax Margin: -75.7%
CERS MA MACD Histogram just turned positiveThis is a Bullish indicator signaling CERS's price could rise from here. Traders may explore going long the stock or buying call options. I identified 41 similar cases where CERS's MACD histogram became positive, and 34 of them led to successful outcomes. Odds of Success: 83%.
Cerus Corp reversal tradeCerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The company produces blood system for platelets and plasma. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.